Peptide purity directly impacts experimental reliability, making quality assessment a critical step before using any research peptide. Multiple analytical techniques work together to provide a complete picture of peptide identity and purity.
Measuring Peptide Purity
Purity is most commonly assessed by reverse-phase HPLC, which separates the target peptide from impurities based on differential hydrophobicity. The purity percentage represents the area of the target peak relative to the total area of all peaks in the chromatogram. Research-grade peptides are typically supplied at greater than 95% purity, while applications such as quantitative binding assays or in vivo studies may require 98% or higher.
It is important to understand that HPLC purity reflects chromatographic purity — the proportion of UV-absorbing material that is the target peptide. It does not account for non-UV-absorbing contaminants such as salts, residual solvents, or water content. Net peptide content, determined by amino acid analysis or nitrogen content measurement, provides the actual amount of peptide substance in a given weight of lyophilized powder, which is essential for accurate concentration calculations.
Identity Confirmation by Mass Spectrometry
Mass spectrometry (MS) confirms that the synthesized peptide has the correct molecular weight. Electrospray ionization (ESI-MS) and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) are the two most common methods. The observed mass should match the calculated monoisotopic or average molecular weight within instrument tolerance. Mass spectrometry can also detect common synthesis artifacts such as deletion peptides (missing one amino acid) or oxidized methionine residues.
Common Impurities and Their Impact
Synthesis-related impurities include deletion sequences, truncation products, racemized amino acids, and incompletely deprotected side chains. Trifluoroacetate (TFA) counterions from HPLC purification can interfere with cell-based assays and should be exchanged to acetate or hydrochloride salts when necessary. Endotoxin contamination, while not a synthesis impurity per se, must be controlled for in vivo applications. Researchers should request endotoxin testing data when planning animal studies.
Frequently Asked Questions
What purity level do I need for my research?
For screening assays and preliminary binding studies, 95% purity is generally sufficient. For quantitative studies, dose-response curves, and in vivo work, 98% or higher is recommended. For NMR structural studies, the highest available purity minimizes spectral complexity from contaminants.
Why does net peptide content differ from purity?
HPLC purity measures the percentage of the target peptide among all peptide-related species. Net peptide content measures how much of the total powder weight is actually peptide versus salts, water, and counterions. A vial containing 10 mg of powder at 98% HPLC purity might have only 70–80% net peptide content, meaning it contains 7–8 mg of actual peptide substance.